Related Experiment Video
Updated: Jun 26, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Epigenetic regulation of microRNAs in acute lymphoblastic leukemia
Jose Roman-Gomez1, Xabier Agirre, Antonio Jiménez-Velasco
1Hematology Department. Reina Sofia Hospital. Avda. Menendez Pidal s/n. 14004 Cordoba. Spain. peperosa@teleline.es
Purpose:
To identify microRNAs (miRNAs) epigenetically regulated in acute lymphoblastic leukemia (ALL).
Methods:
We first examined ALL-derived cell lines for the presence of abnormal levels of two different histone modifications (trimethylation of H3 lysine 4 [K4H3me3] and dimethylation of H3 lysine 9 [K9H3me2]) in the 5'UTR regions around CpG islands of 78 miRNAs by chromatin immunoprecipitation (ChIP)-on-ChIP analysis. Methylation status (methylation-specific polymerase chain reaction [PCR]) and expression (quantitative PCR) of miRNAs showing a pattern of histone modifications linked to a closed chromatin structure were analyzed in a panel of six ALL cell lines and in 353 ALL patients.
Results:
CpG islands around 13 miRNAs disclosed high levels of K9H3me2 and/or low levels of K4H3me3, a pattern of histone modifications underlying a closed chromatin structure associated with repressive gene expression. Complete consistency in the correlation between both histone marks, the presence of DNA methylation around these miRNAs, and their expression patterns was confirmed in the six ALL cell lines. Treatment with 5-Aza-2'-deoxycytidine upregulated the expression levels of these genes, suggesting that epigenetic mechanisms deregulate the expression of these miRNAs. A total of 65% of the ALL samples had at least one miRNA methylated (methylated group). Estimated disease-free survival (DFS) and overall survival (OS) at 14 years were 78% and 71% for nonmethylated patients and 24% and 28% for methylated patients (P = .00001 for both). Multivariate analysis demonstrated that methylation profile was an independent prognostic factor for predicting DFS (P = .0001) and OS (P = .0001).
Conclusion:
Aberrant miRNA methylation is a common phenomenon in ALL that affects the clinical outcome of these patients.
Insights
Epigenetic regulation of microRNAs (miRNAs) is altered in acute lymphoblastic leukemia (ALL). Aberrant miRNA methylation in ALL patients significantly impacts disease-free and overall survival, highlighting its prognostic value.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Acute lymphoblastic leukemia (ALL) is a heterogeneous hematologic malignancy.
- MicroRNAs (miRNAs) play crucial roles in gene regulation and are implicated in various cancers.
- Epigenetic alterations, including DNA methylation and histone modifications, are increasingly recognized as drivers of leukemogenesis.
Purpose of the Study:
- To investigate microRNAs (miRNAs) that are epigenetically regulated in acute lymphoblastic leukemia (ALL).
- To determine the association between miRNA epigenetic modifications and clinical outcomes in ALL patients.
Main Methods:
- Chromatin immunoprecipitation (ChIP)-on-ChIP was used to assess histone modifications (K4H3me3, K9H3me2) in miRNA 5'UTRs in ALL cell lines.
- Methylation-specific PCR and quantitative PCR were employed to analyze miRNA methylation status and expression in ALL cell lines and patient samples.
- The effect of epigenetic drugs (5-Aza-2'-deoxycytidine) on miRNA expression was evaluated.
Main Results:
- Epigenetic modifications associated with closed chromatin structure were identified in 13 miRNAs.
- A strong correlation was observed between histone marks, DNA methylation, and miRNA expression in ALL cell lines.
- Treatment with 5-Aza-2'-deoxycytidine reversed the repressive epigenetic marks and upregulated miRNA expression.
- Aberrant miRNA methylation was detected in 65% of ALL patients.
- MiRNA methylation was significantly associated with poorer disease-free survival (DFS) and overall survival (OS) (P < .00001).
- Multivariate analysis confirmed miRNA methylation profile as an independent prognostic factor for DFS and OS (P < .0001).
Conclusions:
- Aberrant miRNA methylation is a prevalent epigenetic event in acute lymphoblastic leukemia (ALL).
- The methylation status of miRNAs serves as a significant independent prognostic biomarker for predicting clinical outcomes in ALL patients.
- Targeting epigenetic dysregulation of miRNAs may offer potential therapeutic strategies for ALL.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation